The Cultivated B has developed TCB-32, a synthetic molecule that could significantly reduce costs for cultivated meat and other cell-based industries by replacing expensive basic fibroblast growth factor (bFGF). TCB-32 mimics bFGF’s role in stimulating cell growth but remains stable longer, reducing media replacement needs. As a chemically synthesized alternative, it offers more scalable and consistent production compared to fragile bFGF. This innovation addresses major challenges in cell culture, potentially making cultivated meat more affordable and competitive with conventional meat. The discovery has broad implications across biotechnology and biomanufacturing.
